Matt Seefeld is Executive Vice President at MedEvolve and Will Mowe is Executive Director of Rebound Orthopedics and Neurosurgery. Today, Rebound is achieving better bottom-line performance with fewer FTEs. Zero touch claims that require no human intervention now account for 62% of total, and a closed balance net collection rate above benchmark at 98%.
MedEvolve Announces Strategic Marketing Relationship with Veradigm to Enhance Revenue Cycle Management Solutions for Healthcare Organizations
MedEvolve’s Ei suite offers modular solutions that can be added on to Veradigm’s PM & EHR software to optimize the entire revenue cycle.